Aaronson S - Search Results

1

Rewired ERK-JNK signaling pathways in melanoma.

Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S, Ronai Z. Lopez-Bergami P, et al. Among authors: aaronson s. Cancer Cell. 2007 May;11(5):447-60. doi: 10.1016/j.ccr.2007.03.009. Cancer Cell. 2007. PMID: 17482134 Free PMC article.

2

c-Jun regulates phosphoinositide-dependent kinase 1 transcription: implication for Akt and protein kinase C activities and melanoma tumorigenesis.

Lopez-Bergami P, Kim H, Dewing A, Goydos J, Aaronson S, Ronai Z. Lopez-Bergami P, et al. Among authors: aaronson s. J Biol Chem. 2010 Jan 8;285(2):903-13. doi: 10.1074/jbc.M109.075630. Epub 2009 Nov 12. J Biol Chem. 2010. PMID: 19910471 Free PMC article.

3

BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.

Dong J, Phelps RG, Qiao R, Yao S, Benard O, Ronai Z, Aaronson SA. Dong J, et al. Among authors: aaronson sa. Cancer Res. 2003 Jul 15;63(14):3883-5. Cancer Res. 2003. PMID: 12873977

4

Clonal selection in malignant transformation of human fibroblasts transduced with defined cellular oncogenes.

Mahale AM, Khan ZA, Igarashi M, Nanjangud GJ, Qiao RF, Yao S, Lee SW, Aaronson SA. Mahale AM, et al. Among authors: aaronson sa. Cancer Res. 2008 Mar 1;68(5):1417-26. doi: 10.1158/0008-5472.CAN-07-3021. Cancer Res. 2008. PMID: 18316605

5

P53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis.

Han JA, Kim JI, Ongusaha PP, Hwang DH, Ballou LR, Mahale A, Aaronson SA, Lee SW. Han JA, et al. EMBO J. 2002 Nov 1;21(21):5635-44. doi: 10.1093/emboj/cdf591. EMBO J. 2002. PMID: 12411481 Free PMC article.

6

β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors.

Grumolato L, Liu G, Haremaki T, Mungamuri SK, Mong P, Akiri G, Lopez-Bergami P, Arita A, Anouar Y, Mlodzik M, Ronai ZA, Brody J, Weinstein DC, Aaronson SA. Grumolato L, et al. PLoS Genet. 2013;9(8):e1003603. doi: 10.1371/journal.pgen.1003603. Epub 2013 Aug 15. PLoS Genet. 2013. PMID: 23966864 Free PMC article.

7

Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling.

Adamopoulos C, Ahmed TA, Tucker MR, Ung PMU, Xiao M, Karoulia Z, Amabile A, Wu X, Aaronson SA, Ang C, Rebecca VW, Brown BD, Schlessinger A, Herlyn M, Wang Q, Shaw DE, Poulikakos PI. Adamopoulos C, et al. Cancer Discov. 2021 Jul;11(7):1716-1735. doi: 10.1158/2159-8290.CD-20-1351. Epub 2021 Feb 10. Cancer Discov. 2021. PMID: 33568355 Free PMC article.

8

Protection of cells in physiological oxygen tensions against DNA damage-induced apoptosis.

Carrera S, de Verdier PJ, Khan Z, Zhao B, Mahale A, Bowman KJ, Zainol M, Jones GD, Lee SW, Aaronson SA, Macip S. Carrera S, et al. Among authors: aaronson sa. J Biol Chem. 2010 Apr 30;285(18):13658-65. doi: 10.1074/jbc.M109.062562. Epub 2010 Mar 12. J Biol Chem. 2010. PMID: 20228054 Free PMC article.

9

SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors.

Ahmed TA, Adamopoulos C, Karoulia Z, Wu X, Sachidanandam R, Aaronson SA, Poulikakos PI. Ahmed TA, et al. Cell Rep. 2019 Jan 2;26(1):65-78.e5. doi: 10.1016/j.celrep.2018.12.013. Cell Rep. 2019. PMID: 30605687 Free PMC article.

10

An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells.

Bafico A, Liu G, Goldin L, Harris V, Aaronson SA. Bafico A, et al. Cancer Cell. 2004 Nov;6(5):497-506. doi: 10.1016/j.ccr.2004.09.032. Cancer Cell. 2004. PMID: 15542433 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

663 results

Search Page